Loading market dashboard

Financials in GBp. Standardized financial statements.
A compact view of how Yourgene Health Plc turns revenue into operating income and net income.
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £37.56M | £18.29M | £16.61M | £8.88M | £6.15M | £3.08M | £2.08M | £4,767 | £62,106 | £257,681 |
| Revenue Growth? | +105.4% | +10.1% | +87.0% | +44.5% | +99.7% | +48.0% | +43540.2% | -92.3% | -75.9% | 0.0% |
| Cost of Revenue? | £16.20M | £6.91M | £6.39M | £4.27M | £2.97M | £1.80M | £1.75M | £0 | £194,383 | £555,156 |
| Gross Profit? | £21.36M | £11.38M | £10.22M | £4.61M | £3.17M | £1.28M | £328,935 | £4,767 | -£132,277 | -£297,475 |
| Gross Margin? | +56.9% | +62.2% | +61.5% | +51.9% | +51.6% | +41.7% | +15.8% | +100.0% | -213.0% | -115.4% |
| Operating Expenses? | £22.86M | £17.62M | £12.67M | £9.27M | £9.07M | £8.20M | £6.70M | £4.69M | £1.53M | £4.66M |
| Operating Income? | -£2.54M | -£11.71M | -£3.24M | -£4.78M | -£8.60M | -£7.60M | -£12.03M | -£7.54M | -£4.93M | -£4.96M |
| EBITDA? | £1.89M | -£8.46M | -£1.13M | £5.82M | -£4.65M | -£6.13M | -£5.80M | -£4.34M | -£398,057 | -£2.76M |
| Income Before Tax | -£3.19M | -£12.01M | -£3.38M | £3.39M | -£9.54M | -£7.85M | -£12.12M | -£7.45M | -£4.93M | -£4.96M |
| Income Tax Expense | -£1.27M | £174,996 | -£948,186 | £491 | -£55,516 | £8,943 | -£39,545 | £0 | £0 | -£294,822 |
| Net Income? | -£1.92M | -£12.18M | -£2.43M | £3.39M | -£9.48M | -£7.86M | -£12.08M | -£7.45M | -£4.93M | -£4.66M |
| EPS? | £-0.00 | £-0.02 | £-0.00 | £0.01 | £-0.03 | £-0.03 | £-0.06 | £-0.05 | £-0.24 | £-0.51 |
| Diluted EPS? | £-0.00 | £-0.02 | £-0.01 | £0.01 | £-0.03 | £-0.03 | £-0.06 | £-0.05 | £-0.24 | £-0.51 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality